From: Erythropoietin and renin as biological markers in critically ill patients
Parameter | Survivors (n = 31) | Nonsurvivors (n = 13) | P |
---|---|---|---|
Age (years) | 61 ± 10 | 58 ± 11 | NS |
Sex (n) | |||
Male | 14 | 7 | NS |
Female | 17 | 6 | NS |
SAPS II | 50 ± 10.6 | 56 ± 9.5 | NS |
MODS | 12 ± 8.4 | 14 ± 6.9 | NS |
Length of ICU stay (days) | 6.1 (4–21) | 7.4 (5–23) | NS |
Primary site of infection | |||
Lung | 15 | 7 | NS |
Urinary tract | 5 | 3 | NS |
Blood | 8 | 2 | NS |
Skin | 3 | 1 | NS |
Patients on inotropes | |||
Noradrenaline | 20 | 9 | NS |
Noradrenaline/dobutamine | 11 | 4 | NS |
Drug titration (μg/kg per min) | |||
Noradrenaline | 0.7 ± 0.45 | 0.72 ± 0.25 | NS |
Dobutamine | 5 ± 2.2 | 5.2 ± 1.8 | NS |